Tyra Biosciences, Inc. Annual Operating Lease, Payments in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Tyra Biosciences, Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2020 to 2023.
  • Tyra Biosciences, Inc. Operating Lease, Payments for the quarter ending June 30, 2024 was $200K, a 66.7% decline year-over-year.
  • Tyra Biosciences, Inc. Operating Lease, Payments for the twelve months ending June 30, 2024 was $400K, a 50% decline year-over-year.
  • Tyra Biosciences, Inc. annual Operating Lease, Payments for 2023 was $800K, a 167% increase from 2022.
  • Tyra Biosciences, Inc. annual Operating Lease, Payments for 2022 was $300K, a 50% increase from 2021.
  • Tyra Biosciences, Inc. annual Operating Lease, Payments for 2021 was $200K, unchanged from 2020.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $800K +$500K +167% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-19
2022 $300K +$100K +50% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-19
2021 $200K $0 0% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-22
2020 $200K Jan 1, 2020 Dec 31, 2020 10-K 2022-03-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.